These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 7963908)
1. Long-term evaluation of immune status in leprosy patients undergoing multiple drug therapy. Vu TT; Hoang TL; Nguyen DQ; Ho ML; Nguyen DH; Le TH; Dang DT; Nguyen QA; Le TP; Tran HK Int J Lepr Other Mycobact Dis; 1994 Sep; 62(3):365-73. PubMed ID: 7963908 [TBL] [Abstract][Full Text] [Related]
2. Antibodies to phenolic glycolipid-1 and to whole Mycobacterium leprae in leprosy patients: evolution during therapy. Bach MA; Wallach D; Flageul B; Hoffenbach A; Cottenot F Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):256-67. PubMed ID: 3522769 [TBL] [Abstract][Full Text] [Related]
3. A longitudinal study of immunologic reactivity in leprosy patients treated with immunotherapy. Rada E; Ulrich M; Aranzazu N; Santaella C; Gallinoto M; Centeno M; Rodriguez V; Convit J Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):552-8. PubMed ID: 7868953 [TBL] [Abstract][Full Text] [Related]
4. A follow-up study of multibacillary Hansen's disease patients treated with multidrug therapy (MDT) or MDT + immunotherapy (IMT). Rada E; Ulrich M; Aranzazu N; Rodriguez V; Centeno M; Gonzalez I; Santaella C; Rodriguez M; Convit J Int J Lepr Other Mycobact Dis; 1997 Sep; 65(3):320-7. PubMed ID: 9401484 [TBL] [Abstract][Full Text] [Related]
5. Effects of chemotherapy on antibody levels directed against PGL-I and 85A and 85B protein antigens in lepromatous patients. Drowart A; Chanteau S; Huygen K; De Cock M; Cartel JL; De Bruyn J; Launois P; Yernault JC; Van Vooren JP Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):29-34. PubMed ID: 8326178 [TBL] [Abstract][Full Text] [Related]
6. The response to chemotherapy of serum Mycobacterium leprae-specific antigen in multibacillary leprosy patients. Roche PW; Britton WJ; Neupane KD; Failbus SS; Cho SN; Theuvenet WJ Am J Trop Med Hyg; 1991 Jun; 44(6):702-8. PubMed ID: 1858971 [TBL] [Abstract][Full Text] [Related]
7. Antibodies to phenolic glycolipid-I during long-term therapy: serial measurements in individual patients. Miller RA; Gorder D; Harnisch JP Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4):633-6. PubMed ID: 3323367 [TBL] [Abstract][Full Text] [Related]
8. Induction of lepromin positivity following immuno-chemotherapy with Mycobacterium w vaccine and multidrug therapy and its impact on bacteriological clearance in multibacillary leprosy: report on a hospital-based clinical trial with the candidate antileprosy vaccine. Sharma P; Kar HK; Misra RS; Mukherjee A; Kaur H; Mukherjee R; Rani R Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):259-69. PubMed ID: 10575405 [TBL] [Abstract][Full Text] [Related]
9. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls. Klatser PR; Janson AM; Thole JE; Buhrer S; Bos C; Soebono H; de Vries RR Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):178-89. PubMed ID: 9251589 [TBL] [Abstract][Full Text] [Related]
10. Comparison of PCR mediated amplification of DNA and the classical methods for detection of Mycobacterium leprae in different types of clinical samples in leprosy patients and contacts. Torres P; Camarena JJ; Gomez JR; Nogueira JM; Gimeno V; Navarro JC; Olmos A Lepr Rev; 2003 Mar; 74(1):18-30. PubMed ID: 12669929 [TBL] [Abstract][Full Text] [Related]
11. Serological monitoring of the response to chemotherapy in leprosy patients. Roche PW; Britton WJ; Failbus SS; Neupane KD; Theuvenet WJ Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):35-43. PubMed ID: 8326179 [TBL] [Abstract][Full Text] [Related]
13. Mycobacterium leprae particle agglutination in diagnosis and monitoring of treatment of leprosy. Kampirapap K J Med Assoc Thai; 1999 Oct; 82(10):1020-4. PubMed ID: 10561966 [TBL] [Abstract][Full Text] [Related]
14. Follow up of T cells subsets and anti-trisaccharide IgM antibody levels of leprosy patients during daily multidrug therapy. Desforges S; Launois P; Bobin P; Bach MA Acta Leprol; 1989; 7 Suppl 1():169-70. PubMed ID: 2503979 [TBL] [Abstract][Full Text] [Related]
15. Study of HLA-DR expression on skin lesions of leprosy before and during multiple drug therapy. Abdel Latif AM; Essa EA Int J Lepr Other Mycobact Dis; 2002 Jun; 70(2):104-10. PubMed ID: 12211894 [TBL] [Abstract][Full Text] [Related]
16. PGL-I antigen and antibody detection in leprosy patients: evolution under chemotherapy. Chanteau S; Cartel JL; Celerier P; Plichart R; Desforges S; Roux J Int J Lepr Other Mycobact Dis; 1989 Dec; 57(4):735-43. PubMed ID: 2681456 [TBL] [Abstract][Full Text] [Related]
17. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients. Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181 [TBL] [Abstract][Full Text] [Related]
18. Immunochemotherapy with interferon-gamma and multidrug therapy for multibacillary leprosy. Barral-Netto M; Santos S; Santos I; von Sohsten R; Bittencourt AL; Carvalho EM; Barral A; Waters M Acta Trop; 1999 Mar; 72(2):185-201. PubMed ID: 10206118 [TBL] [Abstract][Full Text] [Related]
19. Nasal mucosa and skin of smear-positive leprosy patients after 24 months of fixed duration MDT: histopathological and microbiological study. Ebenezer GJ; Job A; Abraham S; Arunthathi S; Rao PS; Job CK Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):292-7. PubMed ID: 10575409 [TBL] [Abstract][Full Text] [Related]
20. Relapses in leprosy patients treated with rifampicin plus dapsone after varying periods of dapsone monotherapy. Li HY; Ran SP; Weng XM; Li TG; Deng XH; Li FT Indian J Lepr; 2001; 73(1):1-10. PubMed ID: 11326592 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]